-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Nkj6xWMtBaP9uyrsI62lvxsd01+7pni4XvSL/h4noXHiQYMxNQ9xdLI/8Nuc5C9x xPftMogccyjNsBKl/voBpg== 0000950134-05-001091.txt : 20050121 0000950134-05-001091.hdr.sgml : 20050121 20050121114821 ACCESSION NUMBER: 0000950134-05-001091 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050121 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050121 DATE AS OF CHANGE: 20050121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ATS MEDICAL INC CENTRAL INDEX KEY: 0000824068 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 411595629 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-18602 FILM NUMBER: 05540574 BUSINESS ADDRESS: STREET 1: 3905 ANNAPOLIS LA STREET 2: SUITE 105 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: 6125537736 MAIL ADDRESS: STREET 1: 3905 ANNAPOLIS LANE STREET 2: SUITE 105 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 FORMER COMPANY: FORMER CONFORMED NAME: ATS MEDCIAL INC DATE OF NAME CHANGE: 19920803 8-K 1 c91334e8vk.txt FORM 8-K ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: JANUARY 21, 2005 (date of earliest event reported) ATS MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 0-18602 -------------------- MINNESOTA 41-1595629 (State or other jurisdiction (IRS Employer Identification No.) of incorporation) 3905 ANNAPOLIS LANE, SUITE 105 MINNEAPOLIS, MINNESOTA 55447 (Address of Principal Executive Offices) (763) 553-7736 (Registrant's telephone number, including area code) NOT APPLICABLE (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ================================================================================ ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On January 20, 2005, ATS Medical, Inc. (the "Company") issued a press release to report preliminary revenue results for the fourth quarter and full year ended December 31, 2004. The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated by reference. The information in this current report, including the exhibit thereto, is not deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits 99.1 Press Release, dated January 20, 2005, of ATS Medical, Inc. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATS MEDICAL, INC. By: /s/ John R. Judd ------------------------------- John R. Judd Chief Financial Officer Date: January 21, 2005 EXHIBIT INDEX
Exhibit No. Description - ---------- -------------------------------------------------------------- 99.1 Press Release, dated January 20, 2005, of ATS Medical, Inc.
EX-99.1 2 c91334exv99w1.txt PRESS RELEASE EXHIBIT 99.1 Contact: Michael Dale, President/CEO Jack Judd, Chief Financial Officer 763/553-7736 Investors: EVC Group, Inc. Doug Sherk, Jennifer Beugelmans 415/896-6820 Anne Bugge 206/926-5220 FOR IMMEDIATE RELEASE ATS MEDICAL PROVIDES PRELIMINARY REVENUE OUTLOOK FOR FOURTH QUARTER AND FULL YEAR 2004 Full Year Revenue Grows 52% MINNEAPOLIS, January 20, 2005 -- ATS Medical, Inc. (NASDAQ: ATSI) today released preliminary revenue results for the fourth quarter and full year ended December 31, 2004. The Company is providing these preliminary results due to its scheduled presentation at the Piper Jaffray Healthcare Conference in New York City on Tuesday, January 25, 2005 at 2:00 p.m. Eastern Standard Time. Fourth quarter revenue is expected to increase more than 28% to approximately $7.2 million, compared with revenue of $5.6 million reported for the fourth quarter ended December 31, 2003. For the 12 month period ended December 31, 2004, revenue is expected to grow approximately 52% to $28.0 million compared with $18.5 million for the 12 month period ended December 31, 2003. These results are in line with the guidance the Company provided when it reported its 2004 third quarter results on October 27, 2004. Michael Dale, President and CEO said, "We are proud of our strong sales growth across all of our markets, particularly in the United States. During the fourth quarter revenue in the United States grew 39% to $2.5 million, compared with $1.8 million for the fourth quarter of 2003. In the international markets, we also achieved strong revenue growth of 16%, or $4.7 million in sales, compared with $3.8 million for the fourth quarter of 2003. We believe these results underscore the cardiac surgery community's continued embrace of our product and approach, as well as our mission to establish ATS Medical as a leading provider of proprietary technology to the cardiovascular surgeon." ATS Medical, Inc. plans to issue final results for the fourth quarter and full year 2004 and conduct a conference call after market close on Wednesday, February 9, 2005. ABOUT ATS MEDICAL - ----------------- ATS Medical manufactures and markets products and services focused on cardiac surgery. It is headquartered in Minneapolis and is global in scope with sales in more than 45 countries. The ATS Open Pivot heart valve has been implanted in over 100,000 patients and utilizes a unique pivot design resulting in improved performance and a lower risk profile. The ATS Medical web site is http://www.atsmedical.com. SAFE HARBOR - ----------- This Press Release contains forward-looking statements that may include statements regarding intent, belief or current expectations of the Company and its management. Actual results could differ materially from those projected in the forward looking statements as a result of a number of important factors, including regulatory actions, competition, pricing pressures, supplier actions and management of growth. For a discussion of these and other risks and uncertainties that could affect the Company's activities and results, please refer to the Company's filings with the Securities and Exchange Commission to its Form 10-Q for the quarter ended September 30, 2004. ### -----END PRIVACY-ENHANCED MESSAGE-----